Goldman Sachs’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9M | Buy |
900,887
+401,293
| +80% | +$11.5M | ﹤0.01% | 1591 |
|
|
2025
Q1 | $16.8M | Sell |
499,594
-221,675
| -31% | -$7.43M | ﹤0.01% | 1836 |
|
|
2024
Q4 | $36.9M | Sell |
721,269
-65,759
| -8% | -$3.36M | 0.01% | 1302 |
|
|
2024
Q3 | $40.2M | Buy |
787,028
+137,838
| +21% | +$7.04M | 0.01% | 1215 |
|
|
2024
Q2 | $29.1M | Sell |
649,190
-214,917
| -25% | -$9.63M | ﹤0.01% | 1310 |
|
|
2024
Q1 | $40.4M | Buy |
864,107
+213,934
| +33% | +$10M | 0.01% | 1100 |
|
|
2023
Q4 | $23.1M | Buy |
650,173
+97,575
| +18% | +$3.47M | ﹤0.01% | 1460 |
|
|
2023
Q3 | $16.4M | Sell |
552,598
-62,248
| -10% | -$1.85M | ﹤0.01% | 1646 |
|
|
2023
Q2 | $11.1M | Buy |
614,846
+94,648
| +18% | +$1.71M | ﹤0.01% | 1952 |
|
|
2023
Q1 | $8.35M | Buy |
520,198
+386,882
| +290% | +$6.21M | ﹤0.01% | 2146 |
|
|
2022
Q4 | $2.44M | Buy |
133,316
+10,648
| +9% | +$195K | ﹤0.01% | 3149 |
|
|
2022
Q3 | $2.41M | Buy |
122,668
+25,215
| +26% | +$495K | ﹤0.01% | 3228 |
|
|
2022
Q2 | $1.82M | Sell |
97,453
-13,150
| -12% | -$245K | ﹤0.01% | 3510 |
|
|
2022
Q1 | $2.43M | Buy |
110,603
+49,083
| +80% | +$1.08M | ﹤0.01% | 3426 |
|
|
2021
Q4 | $1.75M | Buy |
61,520
+6,095
| +11% | +$173K | ﹤0.01% | 3590 |
|
|
2021
Q3 | $1.17M | Sell |
55,425
-5,380
| -9% | -$113K | ﹤0.01% | 3861 |
|
|
2021
Q2 | $1.15M | Sell |
60,805
-61,547
| -50% | -$1.16M | ﹤0.01% | 3921 |
|
|
2021
Q1 | $1.87M | Sell |
122,352
-5,830
| -5% | -$89.1K | ﹤0.01% | 3433 |
|
|
2020
Q4 | $1.81M | Buy |
128,182
+26,790
| +26% | +$378K | ﹤0.01% | 3129 |
|
|
2020
Q3 | $1.59M | Buy |
101,392
+87,349
| +622% | +$1.37M | ﹤0.01% | 3035 |
|
|
2020
Q2 | $246K | Buy |
+14,043
| New | +$246K | ﹤0.01% | 3911 |
|
|
2019
Q4 | – | Sell |
-72,640
| Closed | -$1.09M | – | 4292 |
|
|
2019
Q3 | $1.09M | Sell |
72,640
-108,350
| -60% | -$1.63M | ﹤0.01% | 3202 |
|
|
2019
Q2 | $4.53M | Buy |
180,990
+166,599
| +1,158% | +$4.17M | ﹤0.01% | 2351 |
|
|
2019
Q1 | $328K | Buy |
14,391
+3,417
| +31% | +$77.9K | ﹤0.01% | 3706 |
|
|
2018
Q4 | $329K | Buy |
+10,974
| New | +$329K | ﹤0.01% | 3565 |
|